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Co-regulated expression of 12/15-lipoxygenase and interleukin-4
mRNAs in rat nephrotoxic nephritis. Arachidonate 12- and 15-lipoxyge-
nase (LO) products are generated in experimental glomerulonephritis.
15-S-HETE (a 15-LO product) and lipoxins (interaction products between
5-LO and either 12-LO or 15-LO) counteract the proinflammatory actions
of leukotrienes. IL-4 has been shown to up-regulate 15-LO gene expres-
sion in human leukocytes. Based on homology with human 15-LO, we
cloned a 0.76 kbp fragment of a rat LO cDNA from leukocytes stimulated
by interleukin-4 (IL-4). The deduced amino acid sequence shows 71.0%
and 60.1% homology to human 15-LO and 12-LO, respectively, and 100%
homology to a recently cloned "leukocyte type" rat 12-lipoxygenase
enzyme, which possesses significant 15-lipoxygenase activity (heretofore
referred to as "12/15-LO"). A deletion mutant was utilized to generate
internal standard cRNA in quantitative PCR assays. Glomerular 12/15-LO
mRNA increased significantly over controls 24 and 48 hours after NTS
injection, then decreased at 72 hours. RNA from NTS glomeruli contained
higher levels of 12/15-LO mRNA than that from unstimulated peripheral
leukocytes, suggesting that 12/15-LO transcription is up-regulated locally
in native and/or infiltrating glomerular cells. Glomerular IL-4 mRNA
increased markedly 16 hours post-NTS, and was then reduced, suggesting
a potential role for T cell-derived IL-4 in directing the expression of
12/15-LO during glomerulonephritis. This represents the first demonstra-
tion of tandem regulated in vivo gene expression for a lymphokine (IL-4)
and a lipoxygenase, both of which promote counter-inflammatory influ-
ences in immune complex-mediated injury.
Lipoxygenases, which are widely distributed in human tissues,
transform unesterified arachidonic acid to biologically active
products that may play roles in both normal and pathophysiologic
processes [reviewed in 1]. In the first few hours following immune
complex deposition and complement-mediated neutrophil (PMN)
infiltration, glomerular generation rates of the arachidonate 5-li-
poxygenase (5-LO) derivatives, leukotrienes (LT) C4, D4, and B4
are stimulated markedly [reviewed in 2]. These LTs exert effects
on glomerular functions which include reduction in the glomeru-
lar ultrafiltration coefficient and glomerular filtration rates, exac-
erbation of proteinuria, and amplification of PMN-provoked
glomerular damage through LTB4-induced PMN chemotaxis,
adhesion, and activation [3, 4]. Following this early burst, glomer-
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ular LT synthesis is suppressed, macrophages replace PMNs, and
glomerular generation of 15-S-hydroxyeicosatetraenoic acid [15-
(S)-HETE], a 15-lipoxygenase derivative of arachidonic acid and
a precursor molecule for lipoxin (LX) biosynthesis, increases
progressively over the ensuing days to weeks [5, 6]. Lipoxins may
also be generated from a precursor 5-lipoxygenase product
(LTA4) by the enzyme 12-lipoxygenase (12-LU) [7]. We and
others have provided evidence supporting the notion that the
activation of the I 5-LO pathway in the wake of early 5-LO activity
is a specific counter-inflammatory signal which limits and antag-
onizes the proinflammatory actions of leukotrienes [reviewed in
6]. 15-S-HETE inhibits the glomerular synthesis of LTB4 in NTS
rats and the chemotactic action of LTB4 for polymorphonuclear
leukocytes (PMN) [5]. Since the glomerular generation of 15-S-
HETE was increased after the induction of NTS [5] and glomer-
ular LTB4 production falls after an initial increase in the same
model, it is conceivable that glomerular production of 15-S-HETE
is regulated to inhibit the inflammatory processes promoted by
LTB4 [6]. Interestingly, other 12/15-LU products, lipoxins, have
been demonstrated to possess their own renal hemodynamic
actions [8, 9] and lipoxin A4 has been shown to antagonize
mesangial cell and glomerular vasoconstrictive actions of LTD4
[91, as well as antagonizing LTD4-induced PMN adhesion to
mesangial cells [10] and LTB4-mediated chemotaxis of human
neutrophils [11]. Taken together, these observations suggest a
generalized anti-inflammatory role for 15-S-HETE and lipoxins to
counter-regulate the pro-inflammatory actions of 5-LU generated
leukotrienes [6, 12].
To examine the mechanisms underlying enhanced 15-LU activ-
ity during the progression of NTS-nephritis, we studied the
regulation of 15-LU gene expression. To attain this objective, we
were prompted by the low sensitivity of Northern blot analysis in
detecting 15-LU expression in cultured glomerular cells, to estab-
lish an alternative procedure for accurately measuring 15-LU
expression. Thus, we have adopted a competitive PCR method
[13, 14] to quantify mRNA levels for this enzyme. This method,
however, requires species-specific eDNA sequences. We therefore
employed PCR cloning using human 15-LO cDNA as a source of
primers to obtain a portion of rat 15-LO eDNA of a size sufficient
for preparing PCR primers and a deletion mutated cRNA to serve
as an internal standard for competitive PCR assays. Further, and
since interleukin-4 (IL-4), a T cell-derived cytokine, is the only
known regulator of the 15-LU gene [15], we examined the time
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course of IL-4 rnRNA expression in the same model of experi-
mental glomerulonephritis.
Methods
Preparation of mRNA and isolation of a lipoxygenase cDNA by
polymerase chain reaction cloning
Based on the hypothesis that rat 15-LO cDNA contains homol-
ogous segments to those of human 15-LO, a PCR cloning approach
was utilized to isolate a cDNA encoding rat 15-LO. The oligonucle-
otide primers were purchased from Midland Certified Reagent
Company (Midland, Texas, USA). The sequences of sense and
antisense primers were; 5'-CGATACACCCTGGAAATFAA-3'
and 5'-ATCCGGAATGCAAAGCTGGACATG-3', which were
based on human 15-LO eDNA sequence (bases 1182-1201 and bases
1917-1940), respectively [16]. These primers were selected from
regions displaying minimal homology to human 12-LU [17]. Total
RNA was prepared by the acid guanidium thiocyanate/phenol!
chloroform extraction procedure [18] from washed leukocytes of
Munich-Wistar rat which had been incubated for six hours in RPMI
1640 (Gibco, Gaithersburg, Maryland) supplemented with 10% fetal
calf serum (Gibco) containing interleukin 4 (100 ng/ml; Genzyme,
Cambridge, Massachusetts, USA). Interleukin 4 was reported to
uniquely and specifically increase the 15-LU mRNA level in mono-
cytes [15]. RNA (0.5 sg) was taken for first-strand cDNA synthesis
(final volume, 5 d) using Molony murine leukemia virus reverse
transcriptase (Gibco) with the downstream antisense oligonucleotide
(5 pmol) as a primer. The mixture was diluted to 20 1d and adjusted
to PCR conditions [10 mivi Tris HC1 (pH 8.3), 50 m'vi KCI, 2 mM
MgCl2, 0.2 m each dNTP, 5 pmol of each primer set and 0.5 unit of
Thermus aquaticus DNA polyrnerase (Taq polymerase, Perkin-
Elmer/Cetus)], and amplification of target DNA was performed as
follows: denaturation at 94°C for 15 seconds; annealing at 37°C for 30
seconds; extension at 72°C for 45 seconds for the first three cycles,
followed by 30 cycles of 94°C, 15 seconds; 50°C, 30 seconds; 72°C, 45
seconds, using GenAmp PCR System 9600 (Perkin-Elmer/Cetus).
The amplified products were electrophoresed in 3.0% agarose gels
and the expected target DNA was excised and purified by glass-
powder elution (Gene Clean kit, BlO 101). The DNA was subjected
to a second round of amplification as described above.
Subcloning and sequencing
The 0.76-kilobase PCR-amplified DNA fragment was sub-
cloned into pCRII (Invitrogen, San Diego, California, USA),
which was designated as pCR76O, using TA cloning kit (Invitro-
gen) in sense orientation. Sequence analysis was done on both
strands directly from double stranded plasmids using Sequenase
(United States Biochemical Corp., Cleveland, OH) and Sp6 and
T7 promoters as primers.
Induction of NTS and preparation of RNAfrom isolated glomeruli
Glomeruli were isolated by sieving technique [5] from 250 g
Munich-Wistar rats before and after (0, 12, 24, 48, and 72 hr) the
intravenous injection of nephrotoxic serum prepared as previously
described [3]. Glomeruli from four rats 24 hours after the
injection of normal rabbit serum served as time-control and
quantitatively compared to those from NTS rats 24 hours after
NTS injection (N = 3) in separate experiments. The glomerular
preparation that was obtained was >95% pure. Total RNA was
prepared as described above.
Preparation of internal standard and quantitative polymerase
chain reaction
The method for competitive PCR amplification with an internal
standard is essentially that described by others [13, 17] and by us
[14]. In brief, the plasmid pCR76O was digested with KpnI and
XbaI, then the fragment containing the 0.76 kb PCR fragment was
subcloned into pBluescriptll SK+ (Stratagene, La Jolla, Califor-
nia, USA), which was designated as pBS76O, in antisense orien-
tation. The pBS76O was cut by Smal and AccI (Fig. 1), then the
AccI end was converted to blunt end using large fragment DNA
polymerase I (Kienow fragment) followed by self-ligation, result-
ing in a plasmid (designated as pBS57O) containing the insert
which lacked the region between the Smal and AccI sites (192 bp
deletion; Fig. 1).' Complimentary RNA was prepared from the
XbaI-digested pBS57O template using T7 polymerase according to
the in vitro transcription protocol of Promega (Promega, Madison,
Wisconsin, USA). After the reaction, the template was digested
with RNase-free DNase I (Bethesda Research Laboratories,
Gaithersburg, Maryland, USA), and the cRNA was purified on a
Quiagen-pack 100 cartridge according to the manufacturer's
protocol and kept stored at —80°C. Quantitation was determined
by absorbance at 260 nrn.
The primers used for quantitative PCR were based on the
eDNA fragment sequenced above (Fig. 1). The sense and anti-
sense primers were 5'-CTGAGCGAGGACTCTFGGAT-3' and
5'-AATFCGGCTTAGCCAGTFCC-3', respectively. The anti-
sense primer was chosen from the region of least homology to
human 12-LU amino acid sequence (Fig. 2). Four micrograms of
total RNA from NTS (24 hr) rat and 4.0 X 10 copies of mutated
cRNA were reverse-transcribed as described above. Serial 1:2
dilutions of the eDNA reaction mixture were PCR-amplified as
described above with additional 15 jtCi of [32P]dCTP. The
amplification conditions were: 94°C for 15 seconds; 57°C for 30
seconds; and 72°C for 45 seconds for 30 cycles. Blank reactions
with no RNA template were carried through the cDNA synthesis
and PCR steps. Ten microgram aliquots of the PCR reactions
were electrophoresed in 3% NuSieve, 1% Sea Kern agarose (FMC
Bioproducts, Rockland, Maine) gels in Tris acetate/EDTA buffer.
Bands were visualized by ethidium bromide staining. Equal size
bands were excised from the gels, and the radioactivity was
determined by Cerenkov counting. Radioactivity from blank
samples carried through all procedures was subtracted as back-
ground level. The amounts of specific PCR-amplified target and
internal standard radioactivity were plotted against total input
RNA and cRNA copy number, respectively, using a log-log scale
[13]. Quantitation was carried out with a correction factor for the
different amounts of dCTP in the double strand PCR products as
described [17, 18]. The sizes of PCR products from mRNA and
internal standard cRNA and the numbers of dCTP residues in the
double-stranded PCR product were 561 bp (dCTP; 300) and 369
bp, (dCTP; 193), respectively. Quantitative analysis by competi-
tive PCR was performed on 1 sg of sample RNA and 1.0 X io
copies of internal standard cRNA in duplicate. In a separate
experiment, double strand PCR product was directly sequenced
by dsDNA Cycle Sequencing System (Life Technologies, Inc.,
Gaithersburg, Maryland, USA) and was confirmed to be com-
posed of a single DNA population whose sequence was identical
to that demonstrated above. To confirm that equal amounts of
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5, AATGTCCGGGCCAGGAGTGACCTGATCTCAGAGAGAGGCTTT
AsnValArgAlaArgSerAspLeulleSerGluArgGlyPhe
TTTGACAAGGCAATGAGCACAGGTGGGGGAGGCCACCTGGATCTTCTCA1GCAAGCTGGA
PheAspLysAlaMetSerThrGlyGlyGlyGlyHisLeuAspLeuLeuLysGlnAlaGly
GCCTTTCTGACCTATTGCTCATTGTGTCCCCCCGATGACTTGGCTGAGCGAGGACTCTTG
AlaPheLeuThrTyrCycSerLeuCysProProAspAspLeuAlaGluArgGlyLeuLeu
GATATCGAGACTTGCTTCTATGCTAAAGACGCCCTGCGACTCTGGCAGATCATGAATCGG
Asp I leGluThrCysPheTyrAlaLysAspAlaLeuArgLeuTrpGlnl leMetAsnArg
TACGTGGTGGGAATGTTCAATCTCCACTACAAGACCGAGAAAGCTGTGCAZGACGACTAT
TyrValValGlyMetPheAsnLeuHisTyrLysThrGluLysAlaValGlnAspAspTyr
GAACTGCAGAGCTGGTGTCGAGAGATCACTGACATTGGTCTTCAAGGGGCCCAGGACAGA
GluLeuGlnSerTrpCysArgGluIleThrAspIleGlyLeuGlnGlyAlaGlnAspArg
GGCTTCCCTACCTCTCTTCAGTCCCGGGCTCAGGCTTGCTATTTCATCACCATGTGCATC
GlyPheProThrSerLeuGlnSerArgAlaGlnAlaCysTyrPhelleThrMetCyslle
TTCACGTGCACCGCACAGCACTCTTCCGTCCATCTTGGCCAGCTGGATTGGTTCTGCTGG
PheThrCysThrAlaGlnHisSerSerValHisLeuGlyGlnLeuAspTrpPheCysTrp
GTTCCTAATGCACCCTGCACCATGCGGCTGCCACCACCCACCACCAGGAAGCAACAATG
ValProAsnAlaProCysThrMetArgLeuProProProThrThrLysGluAlaThrMet
GAGAAGCTGATGGCTACACTGCCCAACCCTAATCAGTCTACTCTCCAGATAAATGTCGTT
GluLysLeuMetAlaThrLeuProAsnProAsnGlnSerThrLeuGlnl leAsnValVal
TGGCTCCTGGGCAGACGCCAAGCTGTTATGGTGCCCCTGGGCCAGCATTCAGAGGAACAC
TrpLeuLeuGlyArgArgGlnAlaValMetValProLeuGlyGlnHisSerGluGluIijs
TTTCCAAA000TGAGGCCAAGGCTGTGCTGA.AGAAGTTCAGAGAGGAACTGGCTAAGCCG
PheProAsnProGluAlaLysAlaValLeuLysLysPheArgGluGluLeuAlaLyspro
AATTCTGCAGAT 3'
AsnSerAlaAsp
Fig. 1. Nucleotide sequence for TKI5LO and the deduced amino acid sequence. Regions for primers for competitive PCR are demonstrated in bold.
Regions which are deleted between SccI and Smal sites in pBS57O are underlined.
RNA were reverse transcribed, the same amounts of each sample 3', respectively. The PCR schedule was 20 cycles of 94°C for 15
were PCR-amplified with f3-actin primers. The sequences of sense seconds, 50°C for 20 seconds, and 72°C for 20 seconds. PCR
and antisense primers for /3-actin were: 5'-GTTCCGATGC- amplification should give 361 bp of fragment originating from /3-actin
CCCGAGGATCF-3' and 5'-GCAlTFGCGGTGCACGATGGA- mRNA [14].
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rat TK15LO
human 15-LO GJP
human 12-LO J3GP
AVLKKFREELAK NSAD
AVLKKFREEL LDKEI
AVL Q D EKEI
Fig. 2. Comparison of the amino acid sequences of lipoxygenases. Residues identical to rat TK15LO clone are represented in boxes. Numbering begins
with the initiator methionine for human 15-LO and human 12-LO. Methionine at position 418 is shown in bold. Region chosen for the antisense primer
for competitive PCR is indicated with asterisks. Dashes have been inserted to optimize sequence alignment. Abbreviations are: human 15-LO, human
15-lipoxygenase; human 12-LO, human 12-lipoxygenase.
RT-PCR of glomerular rat IL-4 mRNA
The primers used for qualitative RT-PCR were based on the rat
IL-4 eDNA [19]. The sense and anti-sense primers were 5'-
TGATGGGTCTCAGCCCCCACCTI7GC-3' and 5 '-cTVFCAGT-
G1TGTGAGCGTGGACTC-3', respectively. Two micrograms of
total RNA from NTS rats (0, 2, 16, and 24 hr) were reverse
transcribed and PCR amplified (reagents supplied by Perkin-
Elmer). Forty cycles of amplification were performed as follows:
94°C for one minute, 55°C for two minutes, and 72°C for two
minutes. PCR products were electrophoresed on 2% SeaKem LE
agarose (FMC Bioproducts, ME) gels and stained with ethidium
bromide.
Southern analysis of IL-4 RT-PCR products
RT-PCR product electrophoresed as described above was
transferred to Hybond-N+ nylon membrane (Amersham) by
capillary Southern blotting [20] and covalently linked by UV-
irradiation using Stratalinker UV crosslinker (Stratagene, La
Jolla, California, USA). Rat IL-4 cDNA was purified from the
plasmid pRIL-4.C10 (gift from Dr. A.J. McKnight, Oxford, UK)
following digestion with Hindill. The cDNA was denatured and
labeled with the enzyme horseradish peroxidase using the en-
hanced chemiluminescence (ECL) direct nucleic acid labeling and
detection system (Amersham). The membrane was hybridized
overnight with the labeled cDNA probe in 0.5 M NaCl solution at
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Fig. 3. Quantitative analysis of 12/15-LO mRNA levels in isolated glomeruli
from rats. Four micrograms of total RNA from NTS rats (24 hr aftcr NTS
injection) and 4.0 X 10° copies of mutated cRNA were reverse-tran-
scribed. Serial 1:2 dilutions of the cDNA reaction mixture were PCR-
amplified for 30 cycles with ["P]dCTP. Ten microgram aliquots of the
PCR reactions were electrophoresed and equal size bands were excised
from the gels, and radioactivity determined. Radioactivity from blank
samples carried through all procedures was subtracted as background. The
amounts of specific PCR-amplified target (0) and internal standard (•)
radioactivity were plotted against total input RNA and cRNA copy
number, respectively, using a log-log scale.
42°C. Following hybridization, the membrane was washed in 0.5 ><
SSC and detection reagents were added as described by the
manufacturer. Autoradiography was performed at room temper-
ature for one minute.
Results
Isolation of a lipoxygenase clone by PCR cloning
A 0.76-kb amplified DNA was purified and sequenced and was
found to contain a single open reading frame (Fig. 1). This cDNA
fragment was named TKI5LO (Fig. 1). The translated sequence
of TKI5LO revealed a sequence with 78.8% and 66.4% nude-
otide identity and 71.0% and 60.1% amino acid identity with
human 15-LO and human 12-LU, respectively (Fig. 2). Compar-
ison with a recently published sequence of a 12-lipoxygenase
eDNA from rat brain [21], however, revealed 100% homology at
both the oligonucleotide and amino acid levels between a portion
of this cDNA and TKISLO.
Quantitative analysis of glomerular gene expression of 12/15-LO in
nephrotoxic serum nephritis rats
Plotting the data obtained from RT-PCR of serial dilutions of
sample RNA and internal standard cRNA (Fig. 3) revealed that
both PCR-amplified products were within the exponential phase
of amplification, which supports the quantitative validity of this
assay system. Numbers of copies of 12/15-LU mRNA from 1 jig of
total glomerular RNA before and after the injection of NTS are
demonstrated in Figure 48. Glomerular 15-LO mRNA copies
from NTS rats (1.8 0.5 x 10° copies/jig total RNA) 24 hours
after NTS injection were significantly increased as compared to
those of time-control rats (7.0 0.6 x io copies/tg total RNA),
which were injected with non-immune rabbit serum 24 hours
before glomerular isolation (Figs. 4 and 5). The same amount of
- 10 total RNA from unstimulated leukocytes obtained from normal
rats (1 Mg) contained less 12/15-LU mRNA than that obtained
from glomeruli isolated from NTS rats 24 hour after NTS
injection (Fig. 6).
Results of lL-4 gene expression and the confirmation of its
identity by Southern blotting are summarized in Figure 7. Gb-
-
z merular IL-4 mRNA increased gradually over the initial 16 hours
post-NTS injection, and then decreased by 24 hours. Southern
blot analysis confirmed the identity of the PCR product as IL-4
mRNA (Fig. 7B). IL-4 mRNA expression in contrcl animals
injected with normal rabbit serum was minimal and did not differ
from baseline over time.
Discussion
In models of experimental glomerulonephritis, there is tempo-
ral concordance between the shift in the glomerular cellular
infiltrate from neutrophils to macrophage/monocyles and the
suppression of glomerular leukotriene 84 (LTB4) generation [2].
We have previously provided evidence supporting the hypothesis
that endogenously generated 15-S-hydroxyeicosatetraenoic acid(15-5-HETE), a product of arachidonie acid metabolism by
15-LU, is involved in this cellular shift and in the suppression of
glomerular LTB4 production [5, 6]. Macrophage/monocyte cell
lines represent a rich source of 15-LU, particularly when stimu-
lated by the lymphokine IL-4 [1, 15, 16]. Since glomerular 15-LU
activity may be a principal determinant of glomerular 15-S-METE
production, we tested the gene expression of 15-LU in the isolated
glomeruli of NTS rats by competitive PCR technique, using
species-specific PCR primers obtained by PCR cloning, to quan-
ti' mRNA levels. Primer sequences based on the already cloned
human 15-LU gene [16] were utilized to clone and sequence a
portion of rat 15-LU cDNA, as outlined above. Since 15-LU
belongs to a family of lipoxygenases, it was important to establish
the identification of the obtained PCR product, especially to
distinguish it from 12-LU [221. We compared the sequences of
nucleotides and deduced amino acids to reported sequences of
corresponding regions of human 15-LU [16] and human 12-LO
[17], to which our clone was 78.8% and 66.4% homologous at the
nucleotide level and 71.0% and 60.1% homologous at the amino
acid level, respectively (Fig. 2). Furthermore, this region con-
tained methionine at amino acid position 418 (in bold type in Fig.
2). Methionine at 418 was proposed as being essential for carbon
position-specific oxygenation of arachidonic acid by 15-LU [22].
These results suggested strongly that TK15-LO was indeed a
portion of rat 15-LU eDNA. These considerations notwithstand-
ing, however, comparison of TK1SLU to a recently cloned "leu-
kocyte type" rat 12-lipoxygenase enzyme [21], revealed 100%
homology, ascertaining the identity of our clone to a portion of
the eDNA encoding this enzyme. importantly, the sequence
reported by Watanabe et al [21] was also found to be identical to
rat 12-LU mRNAs from leukoeytes and lung, and to possess 15-,
as well as 12-lipoxygenase activity [21]. In fact, to date, a separate
enzyme possessing exclusive 15-LU activity has not been identified
in rat, and it is most likely that 15-lipoxygenase products gener-
ated from rat leukocytes arise from the action of this unique
bifunctional enzyme, heretofore referred to as "12/15-LU." The
present findings support this notion, particularly since this enzyme
was inducible by IL-4 and since the antisense primer for compet-
itive PCR (Fig. 1) was chosen from the region of least homology
to human 12-LU amino acid sequence (from amino acid number
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Fig. 4. Sequential changes in 12/15-LU gene
expression in glomeruli isolated from rats before
(0 hr) and after (12 hr, 24 hr, 48 hr, and 72 hr)
the injection of nephrotoxic serum, as determined
by competitive PCR method. Data from time
control normal rabbit serum-injected rats (24 hr
control) is also shown. A. Ethidium bromide-
stained gel containing products amplified for 30
cycles (15-LO, 561 bp; internal standard, 373
bp; J3-actin, 361 bp). B. Calculated numbers of
mRNA copies.
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629-636 of human 12-LO; asterisks in Fig. 2) to avoid co-
amplification of 12-LO mRNA. Direct sequencing of the PCR
product confirmed that it is amplified from a single mRNA strand
which is identical to TKI5LO.
Competitive PCR is sensitive and reliable, provided that mea-
surements are performed within the exponential phase of ampli-
fication for both internal standard and target gene [13, 14, 171.
Since both target sample and internal standard are amplified with
the same primers and parallel standard curves were generated
(Fig. 3), the assay described here can be used quantitatively with
a reasonable degree of confidence. Glomerular 12/15-LO mRNA
increased 24 hours after NTS injection, then decreased toward the
baseline level at 72 hours. The increase in 12/15-LO mRNA 24
hours after the induction of NTS is coincident with the increased
glomerular production of 15-S-HETE [51 and precedes the sup-
pression of glomerular leukotriene B4 generation [51 and the shift
in the glomerular cellular infiltrate from neutrophils to macro-
phage/monocytes [221, findings which suggest that 12/15-LO gene
expression may be closely related to the development of NTS
nephritis. Numbers of mRNA copies, approximately 1 x iO
90:
0<
E
Fig. 5. Quantitative analysis of glomerular expression ofJ2/15-LOmRNA in
normal rabbt serum-injected time-control rats (Control; N = 4) and NTS
rats (NTS; N = 3) injected with rabbit nephrotoxic serum 24 hours prior to
glomerular isolation.
copies per jig of total RNA (Figs. 4B, 5), were relatively low
compared to the numbers for mRNAs for other eicosanoid-
forming enzymes including cyclooxygenase, 5-LU, 12-LU, and
leukotriene A4 hydrolase in cultured human erythroleukemia
cells, which ranged from io to iO copies per jig of total RNA
[17]. The relatively small numbers of 12/15-LU mRNA might
explain the difficulty in detecting this mRNA by northern blot
hybridization analysis [121 and supports the superiority of quan-
titative PCR for the detection of low-expression-rate target
mRNA. These numbers are also smaller than that of 12/15-LU
mRNA in human alveolar macrophages from asthmatic patients
[17], which was 4.15 x iO copies per jig of total RNA. This likely
reflects the heterogeneous nature of the glomerular cell popula-
tion from which total RNA was isolated, and suggests that
12/15-LU mRNA might be expressed in selected type(s) of
glomerular cells, particularly macrophages. Since the higher levels
of 12/15-LU mRNA in nephritic versus non-nephritic glomeruli
might result from the mere presence of a greater number of
leukocytes in inflamed glomeruli, rather than specific induction of
gene expression, we compared the levels of 12/15-LU mRNA in
isolated glomeruli with those in pure peparations of circulating
unstimulated leukocytes. In the same amount of total RNA,
glomeruli from NTS rats expressed higher levels of 12/15-LU
mRNA than unstimulated leukocytes (Fig. 6), suggesting that
12/15-LU activity is regulated at the transcriptional level in
resident and/or infiltrating glomerular cells in the specific setting
of acute immune-mediated injury. Whether this relates to post-
transcriptional events, such as shortened mRNA half-life, remains
to be determined.
Resident mesangial macrophages or infiltrating monocytes rep-
resent likely targets for 12/15-LU gene expression and regulation
during inflammatory injury [15]. Additionally, glomerular epithe-
hal cells may express 12/15-LU, since 15-LU enzyme has been
identified in other epithelial cell lines [15, 16].
The regulation of 15-LU in maerophage/monocyte cell lines has
been investigated rigorously, and the sole cytokine capable of induc-
ing gene expression was IL-4 [151. For this reason, we investigated
whether IL-4 mRNA could be detected in normal and nephritic
Fig. 6. Comparison of 12/15-LO mRNA expression in peripheral unstimu-
lated rat leukocytes and in isolated glomeruli from rats 24 hours after NTS
injection. Starting with equal amounts of total RNA (1 Jig), nephritic
glomeruli express greater amounts of 12/15-LO mRNA than leukocytes.
glomeruli, and whether its level of expression was regulated in a
manner suggestive of a potential role for this lymphokine in the in
situ modulation of 12/15-LU gene activity in NTS nephritis. Not
surprisingly, IL-4 mRNA was hardly detectable in non-nephritic
control glomeruli, since T-lymphocytes, the unique cells capable of
synthesizing IL-4, are present in negligible numbers in the normal
glomerulus. Uf interest, and as demonstrated in Figure 7, IL-4
mRNA is clearly detectable by two hours following induction of
immune injury, peaks at 16 hours, and appears to trend towards
baseline by 24 hours. The time course of IL-4 gene expression is
entirely consistent with the established pattern of lymphocyte infil-
tration in models of glomerular injury [reviewed in 23]. The precise
anatomic basis for intercellular communication between lymphocytes
and target cells expressing 12/is-LU remains to be identified. It is of
interest that the peak expression of the IL-4 mRNA precedes that of
12/15-LU by four to six hours, providing support for the notion that
IL-4 is indeed the regulatory influence for 12/15-LU. This notion is
consistent with the other facets of IL-4-macrophage interactions, in
which IL-4 appears to display "anti-inflammatory" actions [24].
15-LU activity has been implicated in the oxygenation of high density
lipoproteins (HDL), a crucial step in the development of atheroscle-
rotic plaque [25]. It is intriguing to speculate that such mechanisms
might be operative in the renal glomerulus as 12/15-LU activity
appears to be induced over the course of glomerulonephritis [5], a
lesion which ultimately also progresses to sclerosis and fibrosis.
In summary, we have cloned a portion of a rat 12/15-hipoxyge-
nase, demonstrated, quantitatively, regulation of glomerular ex-
pression of 12/15-LU mRNA during rat nephrotoxic serum ne-
phritis, and provided evidence that this induction of gene
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Fig. 7. A. Agarose gel elecirophoresis of IL-4 RT-PCR products. Glomerular mRNA from NTS rats was amplified using primers specific for rat IL-4 and
GAPDH as described in Methods. (B) Southern analysis (autoradiogram) of rat IL-4 RT-PCR product. The amplified DNA shown in (A) was
transferred to nylon membrane and probed with labeled rat IL-4 eDNA as described in Methods.
expression is restricted to the inflamed glomerulus arid is likely
driven by IL-4. Increased glomerular 12/15-LO gene expression
can in turn mediate enhanced glomerular production of anti-
inflammatory eicosanoids, 15-S-HETE and lipoxins. Since the
biosynthesis of lipoxins can be driven by both 15-, as well as 12-LU
activities, these findings might be of particular relavnce to the
recent demonstration of increased lipoxin A4 generation in
immune-mediated glomerular injury [26].
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